Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 9
Submit an article Journal homepage
157
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

A varied approach to left ventricular assist device follow-up improves cost-effectiveness

Mustafa M. Ahmeda Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA
,
Piaopiao Lib Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA
,
Lauren E. Meecea Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA
,
Jiang Bianc Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, FL, USA
&
Hui Shaob Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USACorrespondence[email protected]
Pages 1501-1505 | Received 15 Mar 2021, Accepted 23 Jun 2021, Published online: 20 Jul 2021

References

  • Benjamin EJ, Blaha MJ, Chiuve SE, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–e603.
  • Heidenreich PA, Albert NM, Allen LA, Stroke Council, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–619.
  • U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. Transplant data 1994–2003. 2017 [cited 2020 Jul 29]. Available from: https://optn.transplant.hrsa.gov/data/view-data-reports/annual-report/
  • Rogers JG, Aaronson KD, Boyle AJ, HeartMate II Investigators, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55(17):1826–1834.
  • Kormos RL, Cowger J, Pagani FD, et al. The Society of thoracic surgeons intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019;38(2):114–126.
  • Mehra MR, Goldstein DJ, Uriel N, et al. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018;378(15):1386–1395.
  • Agrawal S, Garg L, Shah M, et al. Thirty-day readmissions after left ventricular assist device implantation in the United States: insights from the nationwide readmissions database. Circ Heart Fail. 2018;11(3):e004628.
  • Akhter SA, Badami A, Murray M, et al. Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis. Ann Thorac Surg. 2015;100(3):884–889.
  • Mehra MR, Salerno C, Cleveland JC, et al. Healthcare resource use and cost implications in the MOMENTUM 3 long-term outcome study. Circulation. 2018;138(18):1923–1934.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Kimura M, Nawata K, Kinoshita O, et al. Readmissions after continuous flow left ventricular assist device implantation. J Artif Organs. 2017;20(4):311–317.
  • Rose EA, Gelijns AC, Moskowitz AJ, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–1443.
  • Clarke A, Pulikottil-Jacob R, Connock M, et al. Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) program. Int J Cardiol. 2014;171(3):338–345.
  • Baras Shreibati J, Goldhaber-Fiebert JD, Banerjee D, et al. Cost-effectiveness of left ventricular assist devices in ambulatory patients with advanced heart failure. JACC Heart Fail. 2017;5(2):110–119.
  • Chew DS, Manns B, Miller RJH, et al. Economic evaluation of left ventricular assist devices for patients with end stage heart failure who are ineligible for cardiac transplantation. Can J Cardiol. 2017;33(10):1283–1291.
  • Rogers JG, Bostic RR, Tong KB, et al. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Circ Heart Fail. 2012;5(1):10–16.
  • Ahmed MM, Magar SM, Jr., Jeng EI, et al. Effects of socioeconomic status on clinical outcomes with ventricular assist devices. Clin Cardiol. 2018;41(11):1463–1467.
  • Clerkin KJ, Garan AR, Wayda B, et al. Impact of socioeconomic status on patients supported with a left ventricular assist device: an analysis of the UNOS database (United Network for Organ Sharing). Circ Heart Fail. 2016;9:e003215.
  • Emani S, Tumin D, Foraker RE, et al. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices. Clin Transplant. 2017;31(2):e12875.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.